keyword
https://read.qxmd.com/read/38687311/the-efficacy-of-punica-granatum-extract-gel-in-the-treatment-of-symptomatic-oral-lichen-planus-in-an-indian-population-a-clinical-study
#1
JOURNAL ARTICLE
Subharina Mahapatra, Manjula Hebbale, Amit Mhapuskar, Rajshekhar Halli, Santosh Jadhav
INTRODUCTION: The autoimmune disorder, oral lichen planus (OLP), primarily affects oral mucous membranes. Current drug treatments are only palliative and have serious side effects. Pomegranate has been used as a potential herbal remedy for the treatment of OLP. MATERIALS AND METHODS: The study consisted of a sample size of 30 individuals who were diagnosed with symptomatic OLP based on both clinical and histological evidence and were equally assigned to Group A (4% topical Punica granatum seed extract gel, which has been customized for this particular study purpose only) and Group B (0...
March 1, 2024: Indian Journal of Pharmacology
https://read.qxmd.com/read/38685610/formulation-characterization-of-lecithin-organogel-as-topical-drug-delivery-system-for-psoriasis-in-vitro-permeation-and-preclinical-evaluation
#2
JOURNAL ARTICLE
Prajakta Bule, Prashant Kadkanje, Ravikiran Kshirsagar, Eswara Rao Puppala, Vegi Ganga Modi Naidu, Naveen Chella
Psoriasis is a chronic inflammatory and proliferative skin disease that causes pathological skin changes and has a substantial impact on the quality of patient life. Apremilast was approved by the US Food and Drug Administration as an oral medication for psoriasis and is beneficial in mild to moderate conditions for chronic usage. However, 5%-7% of withdrawals were reported due to severe side effects. To address the issue, a localized drug delivery strategy via the topical route may be a viable approach. However, poor physicochemical properties make it vulnerable to passing through the skin, requiring a specialized drug delivery system to demonstrate its full potential via a topical route like lecithin organogel...
May 2024: Drug Development Research
https://read.qxmd.com/read/38685527/new-therapeutic-strategies-in-osteoarthritis
#3
JOURNAL ARTICLE
Md Abu Bakar Siddiq, Win Min Oo, David J Hunter
Osteoarthritis is the most prevalent arthritis-type and is a major contributor to chronic joint pain, impaired physical function, and limited mobility. By the end of 2020, a total of 595 million, equal to 7·6% of the global population had osteoarthritis; this figure is expected to rise exponentially by 2050. Even while the disorder's intricate pathophysiology is starting to appear intelligible, we are yet to have a cure for the disorder. Osteoarthritis is typically managed with traditional palliative measures, such as, topical and systemic analgesics, including non-steroidal anti-inflammatory drugs, therapeutic exercise, and braces...
April 27, 2024: Joint, Bone, Spine: Revue du Rhumatisme
https://read.qxmd.com/read/38681290/sorafenib-induced-erythema-multiforme-major-and-severe-hepatic-failure-in-metastatic-hepatocellular-carcinoma-a-case-report
#4
Houda Abrini, Mounia Amzerin, Fatima Zahra El Mrabet
Sorafenib, a kinase inhibitor, is known to cause skin toxicity, which sometimes leads to treatment interruption or drug dose reduction. Erythema multiforme (EM) is one of these dermatologic toxicities induced by sorafenib. We report the case of a 28-year-old male with hepatocellular carcinoma (HCC). Two months after surgery, the patient presented with multiple metastases to the retroperitoneal lymph nodes and lungs. Therefore, systemic therapy with sorafenib was indicated. While receiving the medication, the patient presented signs compatible with EM...
March 2024: Curēus
https://read.qxmd.com/read/38680029/-getting-the-dose-right-revisiting-the-topic-with-focus-on-biologic-agents
#5
REVIEW
Diane R Mould, Richard N Upton
Nearly two decades after the Peck and Cross article '"Getting the dose right: facts, a blueprint, and encouragements" was published, a review of dose recommendations for biologics shows that the success in getting the dose right appears to have improved given the relatively low incidence of drug withdrawals and dosing/label changes. However, the clinical experience with monoclonal antibodies (MAbs) following approval has been less than perfect. In inflammatory diseases, the disease burden changes with time and high treatment failure rates have been reported...
April 28, 2024: Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/38677557/scoping-review-of-non-surgical-treatment-options-for-macular-holes
#6
REVIEW
Yong Min Lee, Bobak Bahrami, Dinesh Selva, Robert J Casson, Weng Onn Chan
Macular holes (MH) are full-thickness retinal defects affecting central vision. While vitrectomy with inner limiting membrane (ILM) peel is the conventional MH treatment, non-surgical alternatives are gaining interest to mitigate surgical risks. This study conducted a comprehensive literature review and analysis of non-surgical MH management. A systematic literature search was conducted on PubMed, Embase, Scopus, and the Cochrane Library from January 1, 1973, to September 13, 2023. Treatments included laser therapy, carbonic anhydrase inhibitors (CAIs), non-steroidal anti-inflammatories (NSAIDs), steroids (topical, subtenons, peribulbar, intravitreal), intravitreal gas, anti-vascular endothelial growth factors (VEGF) and ocriplasmin injections...
April 25, 2024: Survey of Ophthalmology
https://read.qxmd.com/read/38674242/influence-of-the-covid-19-pandemic-on-medical-management-and-on-healthcare-delivery-of-immune-mediated-rheumatic-and-musculoskeletal-diseases-during-the-first-pandemic-period-february-to-july-2020-a-systematic-review
#7
REVIEW
Marco Schlegel, Stefan Bachmann
(1) Background and Objectives : The COVID-19 pandemic influenced the management of patients with immune-mediated rheumatic and musculoskeletal diseases (imRMDs) in various ways. The goal of our systematic review was to determine the influence of the first period of the COVID-19 pandemic (February 2020 to July 2020) on the management of imRMDs regarding the availability of drugs, adherence to therapy and therapy changes and on healthcare delivery. (2) Materials and Methods : We conducted a systematic literature search of PubMed, Cochrane and Embase databases (carried out 20-26 October 2021), including studies with adult patients, on the influence of the COVID-19 pandemic on the management of imRMDs...
April 4, 2024: Medicina
https://read.qxmd.com/read/38673458/topical-treatments-in-atopic-dermatitis-an-expansive-review
#8
REVIEW
Michelle Lazar, Aurore D Zhang, Neelam A Vashi
Atopic dermatitis (AD) is a common inflammatory skin condition found worldwide. It impacts patient quality of life (QoL) and is thought to arise as an inflammatory response to epidermal barrier dysfunction and hypersensitivity. AD can lead to large out-of-pocket costs and increased healthcare expenses over a lifetime. An analysis of all randomized control trials conducted since 1990 on topical therapies for AD were reviewed, including 207 trials in the final analysis. It was found that an average of 226 patients were enrolled over 2...
April 10, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38669120/year-in-review-2023-noteworthy-literature-in-cardiothoracic-critical-care
#9
REVIEW
Sarah Alber, Kenji Tanabe, Andrew Hennigan, Hans Tregear, Samuel Gilliland
This article reviews noteworthy investigations and society recommendations published in 2023 relevant to the care of critically ill cardiothoracic surgical patients. We reviewed 3,214 articles to identify 18 publications that add to the existing literature across a variety of topics including resuscitation, nutrition, antibiotic management, extracorporeal membrane oxygenation (ECMO), neurologic care following cardiac arrest, coagulopathy and transfusion, steroids in pulmonary infections, and updated guidelines in the management of acute respiratory distress syndrome (ARDS)...
April 26, 2024: Seminars in Cardiothoracic and Vascular Anesthesia
https://read.qxmd.com/read/38661491/corneal-complications-related-to-dupilumab-use
#10
JOURNAL ARTICLE
Jenna Tauber, David C Ritterband, Joann J Kang
OBJECTIVES: The aim of this report is to describe atypical corneal complications associated with dupilumab use. METHODS: This is a series of four cases of adult patients with infiltrative or ulcerative keratitis secondary to dupilumab use. RESULTS: All four patients in this series were prescribed dupilumab for the treatment of atopic dermatitis and developed infiltrative or ulcerative corneal lesions. In all cases, corneal disease was successfully managed with immediate discontinuation of dupilumab and topical steroid treatment...
April 25, 2024: Eye & Contact Lens
https://read.qxmd.com/read/38654981/main-issues-in-penetrating-keratoplasty
#11
REVIEW
Jorge L Alió, Sana Niazi, Farideh Doroodgar, Jorge L Alió Del Barrio, Hassan Hashemi, Mohammad Ali Javadi
This review explores contemporary challenges in penetrating keratoplasty (PK), focusing on technical intricacies, technological advancements, and strategies for preventing graft rejection. A systematic literature search from January 2018 to July 2023 was conducted across PubMed, Cochrane, Web of Science, Scopus, and EMBASE. The inclusion criteria comprised studies on PK and its comparison with other corneal pathologies, with emphasis on keratoconus (KC). Two independent reviewers screened studies, extracting relevant data...
2024: Taiwan Journal of Ophthalmology
https://read.qxmd.com/read/38653306/acute-myopic-shift-after-a-single-dose-of-acetazolamide-a-case-report-and-review-of-the-literature
#12
REVIEW
Eirini Kaisari, Hana Abouzeid, Laurent Magnin, Melanie Boeuf, Evangelia Gkaragkani, Ann Schalenbourg, Thomas J Wolfensberger, Pierre-François Kaeser
We report the case of a 32-year-old male who presented with an acute myopic shift as a result of uveal effusion following a single administration of 250 mg acetazolamide. The drug was discontinued and following cycloplegia and topical steroid therapy, we observed progressive deepening of the anterior chamber, reopening of the iridocorneal angle, and complete resolution of the myopic shift after 5 days. A literature review since 1956 identified 23 cases, including ours, which developed a myopic shift after a median time of 24 h (3 - 24) following a median dose of 500 mg (125 - 1000) acetazolamide, with about a third complicated by angle closure ocular hypertension...
April 2024: Klinische Monatsblätter Für Augenheilkunde
https://read.qxmd.com/read/38653297/silicone-oil-tamponade-for-therapy-of-primary-retinal-detachment-in-patients-who-live-at-high-altitudes
#13
JOURNAL ARTICLE
Tim Beltraminelli, Quentin Hessler, Theodor Stappler, Jelena Potic, Thomas J Wolfensberger, Lazaros Konstantinidis
BACKGROUND: Uncomplicated rhegmatogenous retinal detachment (RRD) is mainly treated with vitrectomy and gas tamponade or, alternatively, scleral buckling surgery. However, gas tamponade inflates at high altitudes, causing significant complications. Silicone oil (SO) tamponade volume is unaffected by atmospheric pressure and may be used in patients who live or must undertake travel at high altitudes. PURPOSE: To determine the anatomical and functional outcomes after pars plana vitrectomy (PPV) with SO tamponade in primary uncomplicated RRD...
April 2024: Klinische Monatsblätter Für Augenheilkunde
https://read.qxmd.com/read/38651615/evolving-utilization-of-topical-budesonide-following-endoscopic-sinus-surgery
#14
JOURNAL ARTICLE
Margaret B Mitchell, Neil Bhattacharyya
Topical budesonide irrigations are frequently prescribed after endoscopic sinus surgery (ESS) to manage mucosal inflammation. However, this off-label indication may conflict with health insurance formularies. We sought to quantify the relative frequency of postoperative budesonide prescriptions to determine if this could be considered common practice after ESS. We extracted and analyzed postoperative prescription data for patients undergoing ESS from 2016 to 2022 within our health care system. Overall, among 8157 ESS patients, 15...
April 23, 2024: Otolaryngology—Head and Neck Surgery
https://read.qxmd.com/read/38651550/a-systematic-review-of-randomised-controlled-trials-on-topical-nasal-steroids
#15
REVIEW
Chiara Zeroli, Armela Gorica, Giulia Monti, Paolo Giocondo Maria Castelnuovo, Maurizio Bignami, Alberto Macchi
INTRODUCTION: Intranasal corticosteroids (INCs) are the first line of therapy for chronic sinonasal conditions such as rhinitis and rhinosinusitis. Among these, one of the most frequently used is beclomethasone dipropionate (BDP). Over the years many studies have evaluated the efficacy of BDP as part of therapy for chronic rhinosinusitis (CRS) and allergic rhinitis (AR) along with nasal washes, which seems to be very well tolerated. OBJECTIVE: To analyse the data in the literature regarding the various therapeutic regimens of BDP in different sinonasal disease and their efficacy and tolerability...
April 2024: Acta Otorhinolaryngologica Italica
https://read.qxmd.com/read/38628407/peripapillary-pachychoroid-syndrome-successfully-treated-with-topical-prednisolone-acetate-1-drops
#16
Lojain A Azizalrahman, Abdullah N Almousa, Fadwa Al Adel, Abdulrahman F AlBloushi
Peripapillary pachychoroid syndrome (PPS) is a rare disease characterized by choroidal thickening around the optic disc. Visual acuity might be impaired secondary to the associated peripapillary intraretinal and/or subretinal fluids. We reported a case of a 70-year-old male patient who presented with a gradual bilateral decrease in vision. His best-corrected visual acuity was 20/60 in the right eye and 20/25 in the left eye. Dilated fundus examination showed yellowish peripapillary lesions and intraretinal fluid (IRF) surrounding the optic disc in both eyes...
2024: Saudi Journal of Ophthalmology: Official Journal of the Saudi Ophthalmological Society
https://read.qxmd.com/read/38628035/tyk2-inhibition-with-deucravacitinib-ameliorates-erosive-oral-lichen-planus
#17
JOURNAL ARTICLE
Kim Natalie Stolte, Alberto Mesas-Fernández, Katharina Meier, Edis Kaan Klein, Henrik Dommisch, Kamran Ghoreschi, Farzan Solimani
Erosive oral lichen planus (OLP) is a challenging disease. This T cell driven disorder frequently shows a treatment unresponsive course and strongly limits patients' quality of life. The disease lacks FDA or EMA approved drugs for its treatment and the efficacy of the commonly administered treatments (i.e. topical and systemic steroids, steroid sparing agents) is often only partial. Although the etiopathogenesis of the disease still needs to be fully elucidated, recent advances helped to identify interferon-ɣ (IFN-ɣ) as a pivotal cytokine in OLP pathogenesis, thus making the interference with its signalling a therapeutic target...
April 2024: Experimental Dermatology
https://read.qxmd.com/read/38625386/the-use-of-essential-oils-in-atopic-dermatitis-a-review
#18
REVIEW
Hanisah Azhari, Ng Shiow Fern, Razifah Mohd Razali, Hooi Leong Loo
Atopic dermatitis (AD) has become a common childhood disease that affects a large number of children worldwide and has become a chronic skin disease that cause a huge economical and psychological damage to the whole family. Despite the use of steroids, immunosuppressants and various topical preparation, the prognosis is still poor. Hence, this review aimed to explore the potential of using essential oils (EO) as an active ingredient in managing AD. The review was completed by using Pubmed, Scopus and Medline to search for relevant articles that study pathophysiology of AD, the properties of EO, the use of EO in managing AD and the suitable advanced formulation to incorporate EO...
April 16, 2024: Current Medical Research and Opinion
https://read.qxmd.com/read/38623137/comparison-of-efficacy-of-topical-betamethasone-dipropionate-and-topical-minoxidil-in-patients-with-alopecia-areata
#19
JOURNAL ARTICLE
Sana Aslam, Aqsa Z Awan, Madiha M Iqbal, Saira Saeed, Mariyam Saeed, Zartaj Liaqat, Saad Abdullah Dar, Salamat Ali, Muhammad Ahsan Asif, Haseeb Mehmood Qadri
Background and objective Alopecia areata (AA) is a reiterative and nonscarring type of hair loss that can affect any hairy area of the body, particularly the scalp. It manifests as patchy or confluent hair loss with variations in demographics and ethnicity. There are numerous treatment options available, including topical and systemic steroids, topical minoxidil, dithranol, tacrolimus, psoralen and ultraviolet therapy (PUVA), contact immunotherapy, and oral immunosuppressive drugs. However, no previous contrast for efficacy is present between the topical betamethasone versus topical minoxidil alone in our population...
March 2024: Curēus
https://read.qxmd.com/read/38621336/inhibition-of-macrophage-mapk-nf-%C3%AE%C2%BAb-pathway-and-th2-axis-by-mangiferin-ameliorates-mc903-induced-atopic-dermatitis
#20
JOURNAL ARTICLE
Cheng Lu, ShiJun Deng, YanJiao Liu, ShengJin Yang, DingMei Qin, LiJuan Zhang, Rui-Rui Wang, Yi Zhang
Available online Atopic dermatitis (AD) is a chronic, persistent inflammatory skin disease characterized by eczema-like lesions and itching. Although topical steroids have been reported for treating AD, they are associated with adverse effects. Thus, safer medications are needed for those who cannot tolerate these agents for long periods. Mangiferin (MAN) is a flavonoid widely found in many herbs, with significant anti-inflammatory and immunomodulatory activities. However, the potential modulatory effects and mechanisms of MAN in treating Th2 inflammation in AD are unknown...
April 14, 2024: International Immunopharmacology
keyword
keyword
75908
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.